Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Example 113
Stilbene derivative 156. Aldehyde 153 (0.235 g, 0.73 mmol), 4-methoxycarbonyl-2-nitro methylenetriphenylphosphonium bromide (0.587 g, 1.09 mmol), and K2CO3 (0.252 g, 1.83 mmol) in DMF (5 mL) were stirred at 95-100° C. for 20 h, cooled to rt and poured into 200 mL H2O. An aqueous 1N HCl was added to pH 3.0, and the mixture was extracted with CHCl3 (7×25 mL). Extract was washed with brine, filtered through paper filter, and evaporated. The residue was purified by chromatography on a silica gel column (2×40 cm bed, packed with CHCl3), eluant: CHCl3 to get compound 156 (0.290 g, 79%) as a yellow oil, solidified upon standing.
INDO PH-sensor 157. Stilbene 156 (0.280 g, 0.56 mmol) was heated with P(OEt)3 at 130° C. for 4 h, cooled to rt, and evaporated at 3 mm Hg vacuum. The residue was purified by chromatography on a silica gel column (2×40 cm bed, packed with EtOAc/hexanes (1:2)), eluant: EtOAc/hexanes (1:2) to get compound 157 (0.160 g, 61%) as a greenish-yellow oil.
Sunburst plot showing an overview on the richness of classified metabolite compounds. Broad compound classes are represented in the center while specific classifications are represented on the exterior. Colours correspond to the assigned classes. Due to readability the names of some classes were removed from the plot. An interactive zoomable plot is available in the supplementary vignettes and on Zenodo
Tentatively annotated liverwort specialized metabolites. Full details are found in the Supplementary Information
Compound | Formula | Molar Mass | Ionization | Tentative Feature |
---|---|---|---|---|
Bisabola-1,3,5,7(14),10- pentaene | C15H20 | 200.32 | Positive | FT0671, FT0672 |
Ar-tenuifolene | C15H20 | 200.32 | Positive | FT0671, FT0672 |
Eudesma-1,4(15)-11- triene | C15H22 | 202.23 | Positive | FT0692 |
Myli-4(15)-ene | C15H22 | 202.33 | Positive | FT0692 |
Cis-calamenene | C15H22 | 202.33 | Positive | FT0692 |
Cuparene | C15H22 | 202.33 | Positive | FT0692 |
Xanthorrizol | C15H22O | 218.33 | Positive | FT0828 - FT0832 |
2-cuparenol | C15H22O | 218.33 | Positive | FT0828 - FT0832 |
Cyclocolorenone | C15H22O | 218.33 | Positive | FT0828 - FT0832 |
β-herbertenol | C15H22O | 218.33 | Positive | FT0828 - FT0832 |
Trans-Nerolidol | C15H26O | 222.37 | Positive | FT0861 |
(E)-farnesol | C15H26O | 222.37 | Positive | FT0861 |
3-[2-(3-Methoxyphenyl)ethyl]phenol | C15H16O2 | 228.29 | Positive | FT0923, FT0925 |
3,4′-Dimethoxybibenzyl | C16H18O2 | 242.31 | Positive | FT1057, FT1059 |
1,2-Bis(3-methoxyphenyl)ethane | C16H18O2 | 242.32 | Positive | FT1057, FT1059 |
Lunularic acid | C15H14O4 | 258.1 | Negative | FT0814-FT0820 |
Radulanin A | C19H20O2 | 280.37 | Positive | FT1451, FT1454, FT1458 |
2,2-Dimethyl-5-hydroxy- 7-(2-phenylethyl)- chromene* | C19H20O2 | 280.4 | Positive | FT1454, FT1458 |
4-(3-Methyl-2-butenyl)-5-phenethylbenzene-1,3-diol | C19H22O2 | 282.38 | Positive | FT1480, FT1483, FT1484, FT1487 |
Negative | FT1001, FT1008, FT1009, FT1011 | |||
4-Prenyldihydropinosylvin | C19H22O2 | 282.38 | Positive | FT1480, FT1483, FT1484, FT1487 |
Negative | FT1001, FT1008, FT1009, FT1011 | |||
Radulanin A methyl ether | C20H22O2 | 294.39 | Positive | FT1623, FT1624, FT1625, FT1626, FT1627 |
Negative | FT1111, FT1112 | |||
8-[2-(4-Hydroxyphenyl)ethyl]-3-methyl-2,5-dihydro-1-benzoxepin-6-ol | C19H20O3 | 296.37 | Negative | FT1132, FT1133, FT1135, FT1136, FT1139, FT1140, FT1141, FT1142, FT1143, FT1144, FT1147 |
5-Methoxy-2-(3-methylbut-2-en-1-yl)-3-(2-phenylethyl)phenol | C20H24O2 | 296.41 | Positive | FT1658, FT1660 |
Negative | FT1146, FT1148 | |||
4-(3-Methyl-2-Butenyl)-5-(2-Phenylethyl)-3-Methoxyphenol | C20H24O2 | 296.41 | Positive | FT1658, FT1660 |
Negative | FT1146, FT1148 | |||
2-[(3,3-Dimethyloxiran-2-yl)methyl]-5-(2-phenylethyl)benzene-1,3-diol | C20H24O2 | 296.41 | Positive | FT1658, FT1660 |
Negative | FT1146, FT1148 | |||
3-Methoxy-5-(2-phenylethyl)-2-prenylphenol | C20H24O2 | 296.41 | Positive | FT1658, FT1660 |
Negative | FT1146, FT1148 | |||
2-[(3,3-Dimethyloxiran-2-yl)methyl]-5-(2-phenylethyl)benzene-1,3-diol | C19H22O3 | 298.38 | Negative | FT1167, FT1168 |
Kaempferol 3-methyl-ether | C16H12O6 | 300.26 | Negative | FT1200, FT1201 |
2,2-Dimethyl-5-hydroxy-7-(2-phenylethyl)-2 H-1-benzopyran-6-carboxylic acid | C20H20O4 | 324.38 | Negative | FT1483, FT1484, FT1485, FT1486, FT1489, FT1491, FT1494, FT1496 |
Radulanin E | C20H20O4 | 324.38 | Negative | FT1483, FT1484, FT1485, FT1486, FT1489, FT1491, FT1494, FT1496 |
Radulanin H | C20H20O4 | 324.4 | Positive | FT2017 - FT2020 |
Negative | FT1484-1486, FT1489-1494, FT1496 |